Skip to search formSkip to main contentSkip to account menu

FCE 22101

Known as: FCE-22101 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ritipenem

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic.
The pharmacokinetics of FCE 22101 were studied in rats, rabbits, Cynomolgus monkeys and dogs after intravenous administration… 
1990
1990
Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
The pharmacokinetics of FCE 22101 were studied in eight healthy male subjects who received FCE 22101 intravenously alone or… 
Review
1989
Review
1989
Synthesis and antimicrobial spectrum of FCE 22101 and its orally available ester FCE 22891.
The most efficient routes for the synthesis of FCE 22101, a penem antibiotic characterized by a carbamoyloxymethyl sidechain at C… 
Review
1989
Review
1989
Review of the in-vitro evaluation of FCE 22101.
FCE 22101 is a broad spectrum beta-lactam displaying bactericidal properties, stable to a wide range of clinically relevant beta… 
1989
1989
Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
The inhibitory activity of penem FCE 22101 was compared with those of imipenem and other relevant antibiotics against over 500… 
1989
1989
Pharmacokinetics of FCE 22101 in man following different modes of administration.
Twelve healthy volunteers received single iv doses of either 500 and 1000 mg or 750 and 1500 mg of the sodium salt of FCE 22101… 
1988
1988
The pharmacokinetics and tissue penetration of FCE 22101 following intravenous and oral administration.
One gram each of FCE 22101 and its acetoxymethyl ester (FCE 22891) were administered sequentially to six healthy volunteers… 
1987
1987
Susceptibility of anaerobic bacteria to FCE 22101
The activity of FCE 22101 against 675 strains of anaerobic bacteria was determined by an agar dilution method. Its activity was… 
1987
1987
In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
The minimum inhibitory concentrations (MICs) of two new penems, CGP 31608 and FCE 22101 were evaluated against 993 aerobic Gram… 
1983
1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics
The in vitro activity of FCE 22101, a new semisynthetic penem derivative, was compared with that of ceftriaxone, moxalactam… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)